A study in JAMA Psychiatry involving more than one million children found that those who initiated a treatment of selective serotonin reuptake inhibitors had a 13% higher risk of developing type 2 diabetes, compared with those who did not initiate SSRI treatment. "This potential risk, which is much lower in magnitude than the other known risk factors for [type 2 diabetes], should be weighed against the known benefits and risks of SSRI treatment to help inform treatment decision making in the pediatric population," the researchers wrote.
Study: SSRI treatment may raise T2D risk in children
Sign up for DiabetesPro SmartBrief
News for diabetes health professionals
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.